Table 1.

The clinical, biochemical, and anthropometric parameters of patients depending on the presence of MetS, Me (Q1; Q3).

Indicators	Patients with MetS (n = 46)	Patients without MetS (n = 64)	p-Value
Age, years	39.5 (30; 51)	33 (27.5; 38)	0.001 *
Gender (male, n (%)/female, n (%))	28 (60.9)/18 (39.1)	30 (46.9)/34 (53.1)	0.340
Duration of disease, years	16 (10; 22)	9 (5; 15)	0.001 *
Glucose, mmol/L	5.20 (4.70; 6.00)	4.90 (4.50; 5.27)	0.003 *
Insulin, μIU/mL	17.99 (14.59; 23.01)	12.98 (9.44; 18.50)	0.008 *
HOMA-IR,	3.96 (2.88; 6.34)	2.73 (1.88; 4.15)	0.004 *
Total cholesterol, mmol/L	4.68 (4.02; 5.45)	4.40 (3.83; 5.11)	0.363
Triglycerides, mmol/L	2.02 (1.74; 2.50)	1.10 (0.80; 1.40)	<0.001 *
High-density lipoproteins, mmol/L	0.90 (0.76; 1.10)	1.20 (0.91; 1.40)	<0.001 *
Low-density lipoproteins, mmol/L	2.67 (1.90; 3.50)	2.70 (2.25; 3.16)	0.572
Atherogenic index	4.17 (3.18; 5.39)	2.82 (2.13; 3.66)	<0.001 *
Waist circumference, cm	106 (100; 114)	86.5 (77; 95)	<0.001 *
Body mass index	31.95 (27.65; 36.05)	23.80 (21.90; 28.00)	<0.001 *
Body fat percentage result	37.3 (30.9; 47.8)	29.9 (21.2; 38.9)	<0.001 *
Visceral fat level	10 (9; 13.5)	6 (4; 8)	<0.001 *
Total fat fold, mm	116.0 (93.5; 140.5)	79.0 (58.5; 97.5)	<0.001 *

Me (Q1; Q3), median (lower quartile; upper quartile); HOMA-IR, homeostasis model assessment of insulin resistance. * p < 0.05, statistically significant difference. Comparisons between groups were performed using the chi-square test for gender and the Mann–Whitney U test for the other indicators.